Abstract
Purpose: The association of thrombocytosis with various malignancies has frequently been found. The aim of this study was to evaluate the relations between the platelet counts and colorectal cancer.
Methods: Platelet counts of 126 patients with colorectal cancer treated surgically between 2002 and 2005 were measured before surgery. Platelet counts >400.000/mm3 were considered as thrombocytosis. The relation between thrombocytosis and tumor size, histological type, lymph node metastasis, morbidity and mortality rates were also evaluated.
Results: Thrombocytosis was observed in 54 patients (42.8%). There was a linear correlation between the tumor stage and thrombocytosis but it was not statistically significant (p=0.15). We have observed a statistically significant linear correlation between the mortality rate and thrombocytosis (p=0.0001).
Conclusion: Colorectal cancer associated with thrombocytosis has poor prognosis but the effect of thrombocytosis on morbidity, mortality and survival rate is not clear enough. Further evaluation with larger-prospective studies is warrented.
Keywords:
Colorectal cancer, thrombocytosis, stage
References
1Silvis SE, Turkbas N, Doscherholmen A. Thrombocytosis in patients with lung cancer. JAMA, 1970; 211: 1852-3.
2Hernandez E, Lavine M, Dunton CJ, et al. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer, 1992; 69: 2975-7.
3Symbas NP, Townsend MF, El-Galley, et al. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int, 2000; 86 :203-7.
4Monreal M, Fernandez-Llamazares J, Francesc Julian J, et al. Platelet count and survival in patients with colorectal cancer: a preliminary study. Thromb Haemost, 1998; 72: 916-8.
5Lavie O, Comerci G, Doras V, et al. Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol, 1999; 72: 82-6.
6Poon RT, Fan S, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol, 2001; 19: 1207-25.
7Constantini V, Zacharski LR, Moritz TE, et al. The platelet count in carcinoma of the lung and colon. Thromb Haemost, 1990; 64: 501-5.
8Ikeda M, Furukawa H, Imamura H, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol, 2002; 9: 287-91.
9Schwarz RE, Keny H. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology, 2001; 48 :1493-8.
10Suzuki K, Aiura K, Kitagou M, et al. Platelet counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology, 2004; 51: 847-53.
11Shimada H, Oohira G, Okazumi S, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg, 2004; 198: 737-41.
12Riess L. Zur Pathologischen Anatomie des Blutes. Arch Anat Physiol Wissensch Med, 1872; 39: 237-49.
13Ascensao JL, Oken MM, Ewing SL, et al. Leukocytosis and large cell lung cancer. Cancer, 1987; 60: 903-5.
14In: AJCC Cancer Staging Manual. Colon and Rectum. 6th ed. New York: Springer-Verlag. 2002. p. 113–119.
15Zeinet AG, Marth C, Muller HE, et al. Significance of thrombocytosis in patients with epitelial ovarian cancer. Am J Obstet Gynecol, 1994; 170: 549-54.
16Gislason T, Nou E. Sedimentation rate, leukocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. Eur J Respir Dis, 1985; 66: 141-46.
17Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with pri-mary lung cancer. Eur Respir J, 1996; 9: 1826-30.
18Hefler L, Mayerhofer K, Leibman B, et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumor Biol, 2000; 21: 309-14.
19Lee JK, Hong YJ, Han CJ, et al. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol, 2000; 17: 149-52.
20Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res, 1999; 5: 487-91.
21Ma L, Elliott SN, Cirino G, et al. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci USA, 2001; 98: 6470-5. 22 . Verheul Henk MW, Pinedo MH. The importance of platelet counts and their contents in cancer. Clin Cancer Research, 2003; 9: 3219-21.
22Nakano T, Chahinian AP, Shinjo M et al. Interleukin 6 and its relationship to clinical para-meters in patients with malignant pleural mesothelioma. Br J Cancer, 1998; 77: 907-12.
23Imai T, Koike K, Kubo T et al. Interleukin 6 supports human megakaryocytic proliferation and differentiation in vitro. Blood, 1991; 78: 1969-74.
24Ramakrishnan S, Xu FJ, Brandt SJ et al. Cons-titutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest, 1989; 83: 921-6.
25Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol, 2004; 5: 655-63.
26Sakon M, Kakkar A, Ikeda M et al. Current status of pulmonary embolism in general surgery in Japan. Surg Today, 2004; 34: 805-10.
27Karpothin S, Pearlstein E. Role of platelets in tumor cell metastasis. Ann Intern Med, 1981; 95: 636-41.
28Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer, 1992; 70: 709-13.
29Jelkman W. The role of the liver in the production of thrombopoietin. Eur J Gastroenterol Hepatol, 2001; 13: 791-801.
